Jpmorgan Chase & CO Immuno Precise Antibodies Ltd. Transaction History

Jpmorgan Chase & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$3.8 - $6.08 $75,635 - $121,016	-19,904 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$3.64 - $6.49 $146,389 - $261,008	-40,217 Reduced 66.89%	19,904 $102,000
Q4 2021 Feb 10, 2022	BUY	$5.06 - $6.69 $32,389 - $42,822	6,401 Added 11.92%	60,121 $1.12 Million
Q3 2021 Nov 12, 2021	BUY	$5.14 - $13.22 $276,120 - $710,178	53,720 New	53,720 $1.01 Million

1.9M

Ticker IPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,836,700
Market Cap $12.4M
Description
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.